Tagomics

Our CSO, Rob Neely and CTO, Debora Lucarelli will be attending the @AGBT - Advances in Genome Biology and Technology - 23-26 of February 2025 in Marco Island. Together with Kristi Stephenson and Edward Jan, they will hold a "Tagomics Office Hours" session. The team is looking forward to meeting partners interested in accessing their novel multiomic technology, Interlace™. Drop by the Agilent suite 7016 and/or poster session.

We recently welcomed Shirong Yu to the team! 🎉 Shirong was originally trained in chemistry, earning an M.Sc. before completing a PhD in Molecular Biology. As an MRC research fellow, she dedicated her efforts to developing cutting-edge molecular tools to investigate the mechanisms of DNA damage and repair, with a particular emphasis on their relevance to cancer. After more than a decade in academia, she transitioned to industry, joining Cambridge Epigenetix (now Biomodal), where she spent nine years leading the development of methylation-based assays and platforms. Before joining Tagomics, she played a key role in developing and productising novel Hi-C technologies for interpreting the 3D organisation of the genome. We are excited to welcome Shirong to the team. Her deep expertise in the development of genomics assays will be instrumental in advancing our multiomic biomarker discovery and diagnostic platforms. #Welcome #Tagomics #Team

Next week, our CEO, Jack Kennefick, will be in San Francisco for #JPMWeek2025, meeting with partners and investors to share insights into our innovative multiomic platform and how we’re applying it to advance disease diagnosis and precision medicine.   Interested in learning more? Meet with Jack or catch his presentation at the Biotech Showcase: 🗓 Monday 13 January 🕓 4:15pm PST                                                                                                                  📌 Hilton San Francisco Union Square, Franciscan B (Ballroom Level)   Not able to join us? Discover how we are applying our platform to revolutionise disease diagnosis and advance the development of precision therapies by visiting our website: www.tagomics.com/partners/.   #Multiomics #Diagnostics #PrecisionMedicine

St. Tagolas paid an early visit to the #TagTeam!🎄✨ We set aside our laptops and pipettes to hit the red carpet in style for #Tagmas24, celebrating another phenomenal year at Tagomics! Here’s to even more exciting milestones in the new year! 🎉 Shout out to our Chief Activity Officer (CAO) Calum Mould and Deputy CAO Isobel Deamer (pictured) for organising a fantastic day and evening of celebrations! #MerryChristmas #Tagomics #HappyHolidays

📢 We're making headlines! Check out our double-page spread in today's Cambridge Independent newspaper! 📰 A fantastic article highlighting our recent partnership with Agilent Technologies. #Tagomics #News #Partnership #Multiomics #Epigenomics #Genomics

📢 Tagomics partners with Agilent Technologies to offer a novel solution for multiomic analysis!   We’re delighted to announce that we have entered into a strategic co-marketing agreement with Agilent Technologies, integrating the Agilent SureSelect™ Library Preparation and Target Enrichment system into our Interlace™ multiomics platform. This combined solution provides comprehensive genomic and epigenomic insights from a single sample in a unified workflow. Read the full press release 📰 and our latest application note 📄 where we demonstrate the potential of this combined approach on our website: https://lnkd.in/e29AkMbN 💻 Register for the early access programme: https://lnkd.in/e9esbG85   #Multiomics #Genomics #Epigenetics #Oncology #Diagnostics #Therapeutics

Don't miss The Connectivity Mix, taking place in Birmingham on 17th October! Fantastic to see Jack Kennewick, Co-founder and CEO of Milner Affiliate Tagomics in the speaker line-up 👏👇

Welcome to the team Paulina Siejka-Zielinska! 🎉 Paulina holds a DPhil in Clinical Medicine from the University of Oxford and has extensive postdoctoral experience. Her background combines a strong foundation in epigenetics, liquid biopsy and sequencing assay development with computational skills. During her DPhil, she contributed to the development of novel methods for analysing DNA methylation, including TAPS technology. She successfully used TAPS data to develop computational approaches for predicting cancer from epigenetic and fragmentomic signatures in circulating plasma DNA. In her postdoctoral research, she applied integrative data analysis to deconvolute fine interplay between the epigenome and transcriptome in colonic premalignancy. Her computational experience encompasses diverse datasets such as methylation sequencing, RNA-seq and single-cell omics data. We are excited to welcome Paulina to the team. Her comprehensive understanding of epigenetics and advanced computational skills will unveil the rich biological insights offered by Tagomics' platform. #Welcome #Tagomics #Team

Tagomics Summer Day Out ☀️ Sorry for our slow reply, we were busy punting, picnicking and playing (competing...) in sunny Cambridge! #TeamBuilding #Teamwork #TagTeam

Welcome to the team Nana Mensah! Nana has just completed his PhD in Computational Biology from the Francis Crick Institute and University College London. He developed bioinformatics tools to investigate aberrant DNA methylation in cancers and applied these to studies of advanced prostate cancers, small intestinal neuroendocrine tumours and non small-cell lung cancers. Before embarking on his PhD, he completed the three-year NHS scientist training programme in Clinical Bioinformatics, where he developed bioinformatics pipelines for the rare disease service at Guy’s and St Thomas’ NHS Foundation Trust. We're delighted to have Nana on the team! His skillset will feed into the development of our multiomic biomarker discovery and clinical reporting software. #Welcome #Tagomics #Healthcare #Innovation